Madison, CT, United States of America

Milind Deshpande

This inventor holds 77 USPTO granted patents and 19 published patent applications, plus 2 CIPO patents and 20 EPO patents, primarily in Pharmaceutical Compounds (CPC class C07D). Top assignees: Achillion Pharmaceuticals, Inc., Bristol-Myers Squibb Compnay, Merck + Co., Inc.. Active years: 2002-2025.

USPTO Granted Patents = 77 

% Patents Active = 67.5

 

 

Average Co-Inventor Count = 8.6

ph-index = 22

Forward Citations = 1,052(Granted Patents)

Forward Citations (Not Self Cited) = 489(Dec 10, 2025)


Inventors with similar research interests:


Company Filing History:


Years Active: 2002-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Aryl Compounds
Heteroaryl Compounds
Heterocyclic Compounds
Amide Compounds
Amino Compounds
Phosphonate Compounds
Medical Disorders
Complement Mediated Disorders
Inflammatory Disorders
Disubstituted Compounds
Ether Compounds
Carbamate Compounds
77 patents (USPTO):Explore Patents

Title: Milind Deshpande: Pioneering Innovations in Immune Disorders

Introduction:

Milind Deshpande, a visionary inventor based in Madison, CT, has made significant strides in the world of innovation, particularly in the realm of immune and inflammatory disorders. With a remarkable portfolio of 72 patents, his groundbreaking technologies have revolutionized the field of medical research.

Latest Patents:

Milind's latest patents focus on aryl, heteroaryl, and heterocyclic compounds for the treatment of immune and inflammatory disorders. These compounds target Factor D, a key protein in the complement cascade, and help regulate excessive complement activation. His innovative formulations offer promising solutions for various medical conditions, showcasing his commitment to advancing healthcare technologies.

Career Highlights:

Throughout his illustrious career, Milind has collaborated with renowned companies like Achillion Pharmaceuticals, Inc. and Bristol-Myers Squibb Company. His expertise and dedication have played a pivotal role in driving forward cutting-edge research and development initiatives in the pharmaceutical industry.

Collaborations:

Milind has had the privilege of working alongside esteemed colleagues such as Avinash S Phadke and Dawei Chen. Together, they have fostered a culture of collaboration and innovation, leading to the successful development of novel pharmaceutical compounds.

Conclusion:

In conclusion, Milind Deshpande's relentless pursuit of innovation and his passion for creating life-changing technologies have cemented his position as a prominent figure in the world of inventors and innovators. His pioneering work in immune disorders not only demonstrates his scientific prowess but also underscores his unwavering commitment to improving healthcare outcomes for individuals worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…